Cargando…
Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies
BACKGROUND: Nicotine, the pharmacologically active substance in both tobacco and many electronic cigarette (e-cigarette) liquids, is responsible for the addiction that sustains cigarette smoking. With 8 million deaths worldwide annually, smoking remains one of the major causes of disability and prem...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467963/ https://www.ncbi.nlm.nih.gov/pubmed/32166575 http://dx.doi.org/10.1007/s40262-020-00880-4 |
_version_ | 1783578121946005504 |
---|---|
author | Kovar, Lukas Selzer, Dominik Britz, Hannah Benowitz, Neal St. Helen, Gideon Kohl, Yvonne Bals, Robert Lehr, Thorsten |
author_facet | Kovar, Lukas Selzer, Dominik Britz, Hannah Benowitz, Neal St. Helen, Gideon Kohl, Yvonne Bals, Robert Lehr, Thorsten |
author_sort | Kovar, Lukas |
collection | PubMed |
description | BACKGROUND: Nicotine, the pharmacologically active substance in both tobacco and many electronic cigarette (e-cigarette) liquids, is responsible for the addiction that sustains cigarette smoking. With 8 million deaths worldwide annually, smoking remains one of the major causes of disability and premature death. However, nicotine also plays an important role in smoking cessation strategies. OBJECTIVES: The aim of this study was to develop a comprehensive, whole-body, physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model of nicotine and its major metabolite cotinine, covering various routes of nicotine administration, and to simulate nicotine brain tissue concentrations after the use of combustible cigarettes, e-cigarettes, nicotine gums, and nicotine patches. METHODS: A parent–metabolite, PBPK/PD model of nicotine for a non-smoking and a smoking population was developed using 91 plasma and brain tissue concentration–time profiles and 11 heart rate profiles. Among others, cytochrome P450 (CYP) 2A6 and 2B6 enzymes were implemented, including kinetics for CYP2A6 poor metabolizers. RESULTS: The model is able to precisely describe and predict both nicotine plasma and brain tissue concentrations, cotinine plasma concentrations, and heart rate profiles. 100% of the predicted area under the concentration–time curve (AUC) and maximum concentration (C(max)) values meet the twofold acceptance criterion with overall geometric mean fold errors of 1.12 and 1.15, respectively. The administration of combustible cigarettes, e-cigarettes, nicotine patches, and nicotine gums was successfully implemented in the model and used to identify differences in steady-state nicotine brain tissue concentration patterns. CONCLUSIONS: Our PBPK/PD model may be helpful in further investigations of nicotine dependence and smoking cessation strategies. As the model represents the first nicotine PBPK/PD model predicting nicotine concentration and heart rate profiles after the use of e-cigarettes, it could also contribute to a better understanding of the recent increase in youth e-cigarette use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40262-020-00880-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7467963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-74679632020-09-15 Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies Kovar, Lukas Selzer, Dominik Britz, Hannah Benowitz, Neal St. Helen, Gideon Kohl, Yvonne Bals, Robert Lehr, Thorsten Clin Pharmacokinet Original Research Article BACKGROUND: Nicotine, the pharmacologically active substance in both tobacco and many electronic cigarette (e-cigarette) liquids, is responsible for the addiction that sustains cigarette smoking. With 8 million deaths worldwide annually, smoking remains one of the major causes of disability and premature death. However, nicotine also plays an important role in smoking cessation strategies. OBJECTIVES: The aim of this study was to develop a comprehensive, whole-body, physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model of nicotine and its major metabolite cotinine, covering various routes of nicotine administration, and to simulate nicotine brain tissue concentrations after the use of combustible cigarettes, e-cigarettes, nicotine gums, and nicotine patches. METHODS: A parent–metabolite, PBPK/PD model of nicotine for a non-smoking and a smoking population was developed using 91 plasma and brain tissue concentration–time profiles and 11 heart rate profiles. Among others, cytochrome P450 (CYP) 2A6 and 2B6 enzymes were implemented, including kinetics for CYP2A6 poor metabolizers. RESULTS: The model is able to precisely describe and predict both nicotine plasma and brain tissue concentrations, cotinine plasma concentrations, and heart rate profiles. 100% of the predicted area under the concentration–time curve (AUC) and maximum concentration (C(max)) values meet the twofold acceptance criterion with overall geometric mean fold errors of 1.12 and 1.15, respectively. The administration of combustible cigarettes, e-cigarettes, nicotine patches, and nicotine gums was successfully implemented in the model and used to identify differences in steady-state nicotine brain tissue concentration patterns. CONCLUSIONS: Our PBPK/PD model may be helpful in further investigations of nicotine dependence and smoking cessation strategies. As the model represents the first nicotine PBPK/PD model predicting nicotine concentration and heart rate profiles after the use of e-cigarettes, it could also contribute to a better understanding of the recent increase in youth e-cigarette use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40262-020-00880-4) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-03-12 2020 /pmc/articles/PMC7467963/ /pubmed/32166575 http://dx.doi.org/10.1007/s40262-020-00880-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research Article Kovar, Lukas Selzer, Dominik Britz, Hannah Benowitz, Neal St. Helen, Gideon Kohl, Yvonne Bals, Robert Lehr, Thorsten Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies |
title | Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies |
title_full | Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies |
title_fullStr | Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies |
title_full_unstemmed | Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies |
title_short | Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies |
title_sort | comprehensive parent–metabolite pbpk/pd modeling insights into nicotine replacement therapy strategies |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467963/ https://www.ncbi.nlm.nih.gov/pubmed/32166575 http://dx.doi.org/10.1007/s40262-020-00880-4 |
work_keys_str_mv | AT kovarlukas comprehensiveparentmetabolitepbpkpdmodelinginsightsintonicotinereplacementtherapystrategies AT selzerdominik comprehensiveparentmetabolitepbpkpdmodelinginsightsintonicotinereplacementtherapystrategies AT britzhannah comprehensiveparentmetabolitepbpkpdmodelinginsightsintonicotinereplacementtherapystrategies AT benowitzneal comprehensiveparentmetabolitepbpkpdmodelinginsightsintonicotinereplacementtherapystrategies AT sthelengideon comprehensiveparentmetabolitepbpkpdmodelinginsightsintonicotinereplacementtherapystrategies AT kohlyvonne comprehensiveparentmetabolitepbpkpdmodelinginsightsintonicotinereplacementtherapystrategies AT balsrobert comprehensiveparentmetabolitepbpkpdmodelinginsightsintonicotinereplacementtherapystrategies AT lehrthorsten comprehensiveparentmetabolitepbpkpdmodelinginsightsintonicotinereplacementtherapystrategies |